期刊文献+

过氧化物酶体增殖剂激活受体γ激动剂的降压机制

下载PDF
导出
作者 颜丽 余振球
出处 《高血压杂志》 CSCD 北大核心 2006年第3期171-173,共3页 Chinese Journal of Hypertension
  • 相关文献

参考文献21

  • 1Ogihara T,Rakugi H,et al.Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives[J].Am J Hypertens,1995,8:316-320.
  • 2Honisett SY,Stojanovska L,Sudhir K,et al.Rosiglitazone lowers blood pressure and increases arterial compliance in postmenopausal women with type 2 diabetes[J].Diabetes care,2003,26:3194-3195.
  • 3李光伟,王金平,李春梅,陈燕燕,杨文英,邢小燕,刘克莉,唐玉龙,黎辉.胰岛素增敏剂罗格列酮抗高血压作用探讨[J].中华内科杂志,2004,43(12):907-910. 被引量:55
  • 4Negro R,Dazzi D,Hassan H,et al.Pioglitazone reduces blood pressure in non-dipping diabetic patients[J].Minerva Endocrinol,2004,29:11-17.
  • 5Barroso I,Gurnell M,Crowley VE,et al.Dominant negative mutations in human PPARγ associated with severe insulin resistance,diabetes mellitus and hypertension[J].Nature,1999,402:880-883.
  • 6Itani SI,Ruderman NB,Schmieder F,et al.Lipid induced insulin resistance in human muscle is associated with changes in diacylglycerol,protein kinase C,and kappaB α[J].Diabetes,2002,51:2005-2011.
  • 7Arner P.Insulin resistance in type 2 diabetes:role of fatty acids[J].Diabetes Metab Res Rev,2002,18:S5-9.
  • 8Coetze.[J].Biochcm Biophys Res commun,2001,287:662-670.
  • 9Hotta K,Funahashi T,Bodkin NL,et al.Circulation concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys[J].Diabetes,2001,50:l126-l133.
  • 10Steppan CM,Brown EJ,Wright CM,et al.A family of tisue-specific resistin-like molecules[J].Proc Natl Acad Sci USA,2001,98:502-506.

二级参考文献14

  • 1Steppan CM ,Bailey ST,Bhat S,et al. The hormone resistin links obesity to diabetes. Nature,2001,409(6818) :307-312.
  • 2Sohda T, Kawamatsu Y, Fujita T, et al. Discovery and development of a new insulin sensitizing agent, pioglitazone. Yakugaku Zasshi ,2002,122(11) :909-918.
  • 3Moore G B, Chapman H, Holder J C, et al. Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice. Biochem Biophys Res Commun,2001 ;286(4) :735-741.
  • 4Steppan CM,Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab,2002,13 (1): 18 -23.
  • 5Stumvoll M, Haring HU. Glitazones: clinical effects and molecular mechanisms. Ann Med. 2002,34 (3) :217-224.
  • 6Ryan MJ, Didion SP, Mathur S, et al. PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice. Hypertension, 2004, 43:661-666.
  • 7Raji A, Seely EW, Bekins SA, et al. Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients. Diabetes Care, 2003, 26:172-178.
  • 8He J, Klag MJ, Caballero B, et al. Plasma insulin level and incidence of hypertension in African Americans and whites. Arch Intern Med, 1999,159:498-503.
  • 9Zavaroni I, Bonini L, Gasparini P, et al. Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. Metabolism,1999,48: 989-994.
  • 10Salonen JT, Lakka TA, Lakka HM, et al. Hyperinsulinemia is associated with the incidence of hypertension and dislipidemia in middle-aged men. Diabetes, 1998, 47: 270-275.

共引文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部